List of bibliographic references
Number of relevant bibliographic references: 16.
| Ident. | Authors (with country if any) | Title |
|---|
| 000D91 (2012) |
| Concepts, consequences, and implications of theranosis. |
| 002137 (2008) |
| Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging. |
| 002485 (2008) |
| Development of multivalent radioimmunonanoparticles for cancer imaging and therapy. |
| 002676 (2007) |
| Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues. |
| 002679 (2007) |
| Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma. |
| 002850 (????) |
| Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia. |
| 002870 (2007) |
| Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. |
| 002A47 (2006) |
| Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer. |
| 002C77 (2005) |
| Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody. |
| 002D68 (2005) |
| Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. |
| 002E06 (2005) |
| High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. |
| 002E80 (2005) |
| Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry. |
| 003074 (2004) |
| Radiometals as payloads for radioimmunotherapy for lymphoma. |
| 003241 (2004) |
| Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients. |
| 003390 (2003) |
| Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT. |
| 003392 (2003) |
| Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i -k "Gerald L DeNardo"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i \
-Sk "Gerald L DeNardo" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= Main
|étape= Curation
|type= indexItem
|index= Author.i
|clé= Gerald L DeNardo
}}
| This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024 |  |
